(

JFNNX

)

Global Life Sciences Fund

Sector Experts Seeking Growth through Innovation in Health Care
NAV As of 06/14/19 $56.18

Jump to a section

Fund Facts

Details Performance (As of 06/14/19) Morningstar (As of 05/31/19)
12/31/98 Inception Date
$3.68B Total Net Assets (As of 05/31/19)
GROSS 0.70%
NET 0.70%
Annual Expense Ratio
(As of fiscal year end 09/30/18)
Morningstar Fee Level (As of 05/31/19)
Fee Level Group
Specialty Institutional
(out of 424 funds)
Morningstar Fee Level Low
View Morningstar Fee Level
-0.81% 1 Day Return
11.56% YTD Return
Category
Health
ic_star ic_star ic_star ic_star
133 Funds Rated
Overall Rating
(Based on risk-adjusted returns)
LARGE VALUE
LARGE BLEND
LARGE GROWTH
MID VALUE
MID BLEND
MID GROWTH
SMALL VALUE
SMALL BLEND
SMALL GROWTH
Equity Style Box *
Important Morningstar Information

Overview

Client Commitment

This global health care fund seeks consistent returns by investing in companies addressing unmet medical needs or making the health care system more efficient. We balance the portfolio across pharmaceuticals, biotechnology and services/devices sub-sectors in an effort to achieve consistent outperformance of the benchmark and peers.

Why Invest in the Fund

    Finding Growth in Health Care

  1. The long-term drivers of growth in the health care sector include rapidly accelerating innovation addressing unmet medical needs, powerful global demographic trends and the globalization of health care. Within this environment, the Fund seeks to invest in growth companies that are addressing unmet medical needs or making the health care system more efficient and cost effective.
  2. Dedicated Sector Experts

  3. Our dedicated team of analysts has 95 years of combined experience investing in health care companies. In this complex and rapidly growing sector, we believe it is critical to have an experienced team that seeks to understand both the science and the business of the companies in which they invest.
  4. Deep and Disciplined

  5. We believe the combination of deep, fundamental research and disciplined portfolio construction will lead to consistently strong results relative to both the health care sector and the broader equity market. The Fund is balanced across the sub-sectors of health care and diversified across market-cap segments and geographies.

Competitive Risk-Adjusted Performance

Risk-adjusted performance (alpha) compared to category average as of 3/31/19

Past performance is no guarantee of future results.
Alpha compares risk-adjusted performance of the Fund and Morningstar Peer Group to the MSCI World Health Care Index. Positive alpha means outperformance on a risk-adjusted basis.

Featured Insights

Performance

RETURNS

(As of 03/31/2019)
(As of 05/31/2019)
Inception: Dec 31, 1998 3M YTD 1YR 3YR 5YR 10YR Since Inception
Global Life Sciences Fund – N Shares 13.90% 13.90% 14.64% 13.74% 11.63% 18.64% 11.50%
MSCI World Health Care Index 8.14% 8.14% 12.23% 9.92% 8.05% 14.00% 6.14%
S&P 500® Index 13.65% 13.65% 9.50% 13.51% 10.91% 15.92% 6.22%
Inception: Dec 31, 1998 3M YTD 1YR 3YR 5YR 10YR Since Inception
Global Life Sciences Fund – N Shares -4.40% 7.33% 4.08% 9.14% 10.11% 17.11% 11.08%
MSCI World Health Care Index -4.10% 2.83% 5.21% 6.43% 6.48% 12.61% 5.83%
S&P 500® Index -0.67% 10.74% 3.78% 11.72% 9.66% 13.95% 6.03%
Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold.
View Fees and Expenses
Performance for Class N Shares that includes periods prior to 1/26/18 reflects the performance of one or more share classes of the Fund or a predecessor fund, adjusted, where applicable and permitted, for differing fees and expenses. See the Fund’s prospectus for further details.

MORNINGSTAR PERCENTILE

(As of 03/31/2019)
(As of 05/31/2019)
1 YR 3 YR 5 YR 10 YR SINCE INCEPTION
Percentile Ranking (%) 21 34 25 24 10
Health Category
Rank/Count
34/146 43/140 27/133 26/122 7/59
1 YR 3 YR 5 YR 10 YR SINCE INCEPTION
Percentile Ranking (%) 27 41 27 23 8
Health Category
Rank/Count
45/149 47/141 29/134 25/123 5/59

CALENDAR YEAR PERFORMANCE

GROWTH OF A $10,000 HYPOTHETICAL INVESTMENT

Source: Morningstar, Inc.
This graph compares fund performance to that of the fund’s Morningstar category average and benchmark(s).

RETURNS-BASED STATISTICS

(As of 05/31/19 CLASS I SHARES)

RISK / REWARD
VS. MSCI WORLD HEALTH CARE INDEX

3 YEAR 5 YEAR
Information Ratio 0.49 0.55
Alpha 2.15 2.63
Tracking Error 5.93 6.89
Beta 1.13 1.21
R-Squared (%) 85.34 84.26

UP AND DOWN MARKET CAPTURE (%)
VS. MSCI WORLD HEALTH CARE INDEX

3 YEAR 5 YEAR
Up Capture Ratio 121.90 130.32
Down Capture Ratio 107.97 112.50

STANDARD DEVIATION

3 YEAR 5 YEAR
Global Life Sciences Fund 14.90 16.11
MSCI World Health Care Index 12.16 12.22

SHARPE RATIO

3 YEAR 5 YEAR
Global Life Sciences Fund 0.54 0.59
MSCI World Health Care Index 0.42 0.46

ANNUAL FEES & EXPENSES

(As of Fiscal Year End, 09/30/18)

CLASS N SHARES
Management Fees 0.64%
12b-1 Fees -
Other Expenses 0.06%
Total Gross Expenses 0.70%
Waivers -
Total Net Expenses 0.70%

Characteristics

TOP HOLDINGS

(As of 05/31/2019)

% of Fund
Merck & Co Inc 4.43
Novartis AG (ADR) 3.53
Abbott Laboratories 3.05
UnitedHealth Group Inc 2.99
Anthem Inc 2.78
Thermo Fisher Scientific Inc 2.77
Takeda Pharmaceutical Co Ltd 2.76
AstraZeneca PLC 2.71
AbbVie Inc 2.55
Neurocrine Biosciences Inc 2.34
TOTAL 29.91

PORTFOLIO CHARACTERISTICS

(As of 05/31/19)

FUND INDEX
Number of Holdings
Equity Issues
90
143
Market Capitalization
Weighted Average
$73.14B
$115.93B
Portfolio Turnover Rate
(1-year trailing)
42.20%
-
Price/Earnings Ratio
(1-year forward)
18.97
19.24
Price/Book Ratio
(1-year forward)
5.15
5.98
Earnings Growth Rate
(1-year forward)
8.49%
7.31%

DEVELOPED VS. EMERGING MARKET

(As of 05/31/19)

% OF FUND % OF INDEX
U.S. 81.26 69.62
Non-U.S. Developed 18.10 30.38
Cash & Equivalents 0.64 -

SECTOR ALLOCATION

(As of 05/31/19)

% OF FUND % OF INDEX
Health Care 99.19 100.00
US Industrials 0.17 -
Cash & Equivalents 0.64 -

MARKET CAPITALIZATION RANGE OF EQUITY HOLDINGS

(As of 05/31/2019)

% OF FUND % OF INDEX
Over $100B 28.11 46.01
$50B to $100B 20.15 22.32
$10B to $50B 19.73 27.13
$5B to $10B 9.48 4.11
$1B to $5B 14.02 0.30
$500M to $1B 2.29 -
$250M to $500M 0.90 -
N/A 4.51 0.14

REGIONAL ALLOCATION

(As of 05/31/19)

% OF FUND % OF INDEX
North America 81.29 70.08
Europe 14.82 21.81
Japan 3.25 5.94
Cash & Equivalents 0.64 -

Commentary & Literature

1Q19 Portfolio Commentary Highlights

  • Health care stocks rebounded during the period along with a broad recovery in equities. A wave of mergers and acquisitions also helped propel the sector.
  • The Fund outperformed both its primary and secondary benchmarks.
  • Despite uncertainty from potential policy changes in the U.S. and the 2020 election cycle, we believe the sector’s rapid pace of innovation will continue to drive growth.

Read The Full Commentary